An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.
Christos ChouaidLise BosquetNicolas GirardAnna KronMatthias SchefflerFrank GriesingerMartin SebastianJose TrigoSantiago ViteriCraig S KnottBernardo RodriguesNora RahhaliJedelyn CabrietoJoris DielsNolen J PerualilaClaudio A SchioppaJan SermonRaphael TouegNicole ErdmannJanka MielkeMehregan Nematian-SamaniCristina Martin-FernandezInnocent PfairaTracy LiParthiv MahadeviaJürgen WolfPublished in: Advances in therapy (2023)
CHRYSALIS: NCT02609776.